Skip to main content
Premium Trial:

Request an Annual Quote

Biosite and Oxford Partner on Colorectal Cancer Biomarker Study

NEW YORK, April 4 (GenomeWeb News) - Biosite and Oxford Genome Sciences today said they will co-evaluate protein-based disease markers for colorectal cancer.


Under the terms of the collaboration, Oxford will identify at least 25 proteins from blood and tissue samples from relapsing colorectal cancer patients, and Biosite will have the rights to develop blood-based diagnostic tests using one or more of the biomarkers.


Financial terms of the agreement were not disclosed.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.